Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiya Yu

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Cancer Research|November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristicsJoseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cancer Immunology Research|November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrestNicolas Acquavella, David Clever, Zhiya Yu, et al.
Nature|June 4, 2013
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasisRahul Roychoudhuri, Kiyoshi Hirahara, Kambiz Mousavi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
The Journal of Clinical Investigation|December 15, 2015
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapyChristopher A Klebanoff, Christopher D Scott, Anthony J Leonardi, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Cancer Research|November 30, 2014
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristicsJoseph G Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, et al.
Cancer Immunology Research|November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrestNicolas Acquavella, David Clever, Zhiya Yu, et al.
Nature|June 4, 2013
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasisRahul Roychoudhuri, Kiyoshi Hirahara, Kambiz Mousavi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.
The Journal of Clinical Investigation|December 15, 2015
Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapyChristopher A Klebanoff, Christopher D Scott, Anthony J Leonardi, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.
Pageof 9